Cost of migraine management: a pharmacoeconomic overview.
Migraine is a chronic, sometimes debilitating, condition that tends to afflict young people who are otherwise healthy and productive. Because diagnostic criteria and effective treatment modalities have not been well taught to physicians, the condition is often undiagnosed, misdiagnosed, and mismanaged, causing unnecessary pain, hardship to the individual, disability, loss of productivity, and increased expense to the healthcare system. This paper discusses a rational approach to the behavioral and pharmacologic treatment of migraine, highlighting the relative costs of preventive and acute care therapies. Several cases are presented to illustrate how the costs of inefficiently managed migraine therapy can be decreased even by using medications that have a higher per-dose cost, as they decrease the pain and disability and actually lower the total cost of managing the patient with migraine.
Rapoport
A M
AM
New England Center for Headache, Stamford, CT 06902, USA. nerve1@webquill.com
Adelman
J U
JU
D000208:Acute Disease / Q000191:economics; D000700:Analgesics / Q000191:economics* / Q000627:therapeutic use; D002908:Chronic Disease / Q000191:economics; D017281:Cost of Illness; D019468:Disease Management; D016527:Drug Costs; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy / Q000191:economics* / Q000523:psychology; D010353:Patient Education as Topic; D011315:Preventive Medicine; D012064:Relaxation Therapy; D013315:Stress, Psychological / Q000517:prevention & control; D014481:United States